Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381180 · ClinicalTrials.gov registry record · Phase 1
Warrior CARE: Cannabis Behavioral Health
A Phase 1 study, sponsored by Wayne State University.
- Not yet
- Registry status
- Phase 1
- Development phase
- 500
- Enrollment target
NCT06381180 is a Phase 1 study that has not yet begun recruiting, run by Wayne State University. The registered enrollment target is 500 participants.
The verdict
NCT06381180, a Phase 1 study, has not yet begun recruiting, sponsored by Wayne State University.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 500 participants
- Enrollment target
Study Summary
This study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.
Interventions
- DRUG Placebo
- DRUG Cannabidiol
- DRUG Tetrahydrocannabinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2030-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06381180
The ClinicalTrials.gov registry entry for NCT06381180 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06381180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06381180 about?
NCT06381180 is a clinical study titled "Warrior CARE: Cannabis Behavioral Health". This study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.
What is the current status of trial NCT06381180?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 500 participants. The study started on 2025-09-22. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT06381180?
The interventions under investigation include: Placebo (DRUG), Cannabidiol (DRUG), Tetrahydrocannabinol (DRUG).
Who is sponsoring clinical trial NCT06381180?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.